COVID-19 and the impact on Alzheimer’s Disease Pathology

“Many studies, past and recent, suggest a connection between viral infections and an increased risk of neurodegeneration, raising concerns about the neurological effects of COVID-19 and the possibility that it may contribute to Alzheimer's disease (AD) onset or worsen already existing AD pathology…”

Furman et al. - Journal of Neurochemistry - 2023

To read this article about how COVID-19 may affect the brain, click on the picture above or the “Learn More” button below.

Please note that this article was written by Susana Furman, Kim Green and Thomas E. Lane and published in the Journal of Neurochemistry in September of 2023 and it provides much food for thought.

Hint: Read the abstract and conclusion for a synopsis.

Did you know that research has shown that there is an increased chance of blood clotting in those with long COVID according to Dr. Ziyad Al-Aly of the VA’s St. Louis Health Care System?

Click on the “Learn More” button below to read Judy George, Deputy Managing Editor of MedPage Today’s January 18, 2024 article: Blood Protein Changes may unravel Long-COVID Mysteries .

How exciting that researchers are now speculating that “Links between complement and coagulation systems could lead to long COVID therapies”…

Previous
Previous

Reducing dietary advanced glycation end products to slow progression of cognitive decline and Alzheimer’s disease

Next
Next

Nutrition Research and Education for Neurologic Disorders!